Resultados de la búsqueda 71-80 of 10546 for Lymphopenia

  1. Mayo Clinic Cancer Physician Update - September 2025

    Page 1.

  2. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  3. Cancer Physician Update e-Edition, August 2015

    Orthopedic surgeons use team-based protocols and highly porous metal components such as cups and augments reinforced with cages to help patients who require ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma (MelMarT). Scottsdale/Phoenix, Ariz. The purpose of ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and CA19-9 level in ...

  9. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The overall objective of this study is to define genes causing cystic kidney disease and to determine the degree to which variants at these ...

  10. Cirugía - Ensayos clínicos - Mayo Clinic

    To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, if possible, ...